Amylyx Pharmaceuticals (AMLX)
(Real Time Quote from BATS)
$1.76 USD
-0.17 (-8.81%)
Updated May 9, 2024 10:34 AM ET
4-Sell of 5 4
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: BMO |
6/2024 | $-0.38 | 0.00% |
Earnings Summary
For their last quarter, Amylyx Pharmaceuticals (AMLX) reported earnings of -$0.46 per share, missing the Zacks Consensus Estimate of $0.24 per share. This reflects a negative earnings surprise of 291.67%. Look out for AMLX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year increase of 1100%.
Earnings History
Price & Consensus
Zacks News for AMLX
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
AMLX: What are Zacks experts saying now?
Zacks Private Portfolio Services